These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23440494)

  • 1. RNA interference-mediated FANCF silencing sensitizes OVCAR3 ovarian cancer cells to adriamycin through increased adriamycin-induced apoptosis dependent on JNK activation.
    He M; Sun HG; Hao JY; Li YL; Yu JK; Yan YY; Zhao L; Li N; Wang Y; Bai XF; Yu ZJ; Zheng ZH; Mi XY; Wang EH; Wei MJ
    Oncol Rep; 2013 May; 29(5):1721-9. PubMed ID: 23440494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene silencing of FANCF potentiates the sensitivity to mitoxantrone through activation of JNK and p38 signal pathways in breast cancer cells.
    Li Y; Zhao L; Sun H; Yu J; Li N; Liang J; Wang Y; He M; Bai X; Yu Z; Zheng Z; Mi X; Wang E; Wei M
    PLoS One; 2012; 7(8):e44254. PubMed ID: 22952942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Fanconi anemia pathway sensitizes to DNA alkylating agents by inducing JNK-p53-dependent mitochondrial apoptosis in breast cancer cells.
    Zhao L; Li Y; He M; Song Z; Lin S; Yu Z; Bai X; Wang E; Wei M
    Int J Oncol; 2014 Jul; 45(1):129-38. PubMed ID: 24789349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Fanconi anemia/BRCA pathway is involved in DNA interstrand cross-link repair of adriamycin-resistant leukemia cells.
    Yao C; Du W; Chen H; Xiao S; Huang L; Chen F
    Leuk Lymphoma; 2015 Mar; 56(3):755-62. PubMed ID: 24996439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA interferences targeting the Fanconi anemia/BRCA pathway upstream genes reverse cisplatin resistance in drug-resistant lung cancer cells.
    Dai CH; Li J; Chen P; Jiang HG; Wu M; Chen YC
    J Biomed Sci; 2015 Sep; 22(1):77. PubMed ID: 26385482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway.
    Wang Z; Li M; Lu S; Zhang Y; Wang H
    Cancer Biol Ther; 2006 Mar; 5(3):256-60. PubMed ID: 16418574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of Fanconi anemia genes FANCD2 and FANCF in the molecular basis of drug resistance in leukemia.
    Yao C; Du W; Chen H; Xiao S; Huang L; Chen FP
    Mol Med Rep; 2015 Jun; 11(6):4605-10. PubMed ID: 25647473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response.
    Lin S; Yu L; Song X; Bi J; Jiang L; Wang Y; He M; Xiao Q; Sun M; Olopade OI; Zhao L; Wei M
    Cell Death Dis; 2019 Sep; 10(9):666. PubMed ID: 31511498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential role of c-Jun-NH2-terminal kinase on synergy induction of apoptosis by TRAIL plus ADM in ADM resistant MCF-7/ADM cells.
    Li F; Meng L; Xing H; Zhou J; Wang S; Huang L; Xu G; Zhu H; Lu Y; Ma D
    Apoptosis; 2006 Jul; 11(7):1239-46. PubMed ID: 16703262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
    Siddique MA; Nakanishi K; Taniguchi T; Grompe M; D'Andrea AD
    Exp Hematol; 2001 Dec; 29(12):1448-55. PubMed ID: 11750104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNAi-mediated knockdown of FANCF suppresses cell proliferation, migration, invasion, and drug resistance potential of breast cancer cells.
    Zhao L; Li N; Yu JK; Tang HT; Li YL; He M; Yu ZJ; Bai XF; Zheng ZH; Wang EH; Wei MJ
    Braz J Med Biol Res; 2014 Jan; 47(1):24-34. PubMed ID: 24345874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Fanconi Anemia/BRCA signaling pathway: disruption in cisplatin-sensitive ovarian cancers.
    D'Andrea AD
    Cell Cycle; 2003; 2(4):290-2. PubMed ID: 12851475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel synthetic analog of Militarin, MA-1 induces mitochondrial dependent apoptosis by ROS generation in human lung cancer cells.
    Yoon DH; Lim MH; Lee YR; Sung GH; Lee TH; Jeon BH; Cho JY; Song WO; Park H; Choi S; Kim TW
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):659-71. PubMed ID: 24161344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein Kinase RNA-Like Endoplasmic Reticulum Kinase-Mediated Bcl-2 Protein Phosphorylation Contributes to Evodiamine-Induced Apoptosis of Human Renal Cell Carcinoma Cells.
    Wu WS; Chien CC; Chen YC; Chiu WT
    PLoS One; 2016; 11(8):e0160484. PubMed ID: 27483435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of fanconi anemia complementation group f exhibits potent chemosensitization of mitomycin C activity in breast cancer cells.
    Yu J; Zhao L; Li Y; Li N; He M; Bai X; Yu Z; Zheng Z; Mi X; Wang E; Wei M
    J Breast Cancer; 2013 Sep; 16(3):291-9. PubMed ID: 24155758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SM‑164 enhances the antitumor activity of adriamycin in human U2‑OS cells via downregulation of X‑linked inhibitor of apoptosis protein.
    Chen J; Chen X; Chen X; Sun H; Yang D
    Mol Med Rep; 2019 Jun; 19(6):5079-5086. PubMed ID: 31059038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas.
    Moes-Sosnowska J; Rzepecka IK; Chodzynska J; Dansonka-Mieszkowska A; Szafron LM; Balabas A; Lotocka R; Sobiczewski P; Kupryjanczyk J
    Cancer Biol Ther; 2019; 20(6):843-854. PubMed ID: 30822218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 17β-Estradiol activates GPER- and ESR1-dependent pathways inducing apoptosis in GC-2 cells, a mouse spermatocyte-derived cell line.
    Chimento A; Sirianni R; Casaburi I; Ruggiero C; Maggiolini M; Andò S; Pezzi V
    Mol Cell Endocrinol; 2012 May; 355(1):49-59. PubMed ID: 22306083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors.
    Taniguchi T; Tischkowitz M; Ameziane N; Hodgson SV; Mathew CG; Joenje H; Mok SC; D'Andrea AD
    Nat Med; 2003 May; 9(5):568-74. PubMed ID: 12692539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer.
    Lim SL; Smith P; Syed N; Coens C; Wong H; van der Burg M; Szlosarek P; Crook T; Green JA
    Br J Cancer; 2008 Apr; 98(8):1452-6. PubMed ID: 18414472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.